Hydrophobic and Hydrophilic IOLs in Patients with Uveitis - A Randomised Clinical TrialShow others and affiliations
2025 (English)In: Clinical Ophthalmology, ISSN 1177-5467, E-ISSN 1177-5483, Vol. 19, p. 373-383
Article in journal (Refereed) Published
Abstract [en]
PURPOSE: To compare inflammatory response, visual acuity, and complications of two intraocular lenses (IOLs) in patients with and without uveitis. SETTING: Tertiary referral centre at Sahlgrenska University Hospital/Mölndal, Sweden.
DESIGN: Prospective randomised controlled trial.
PATIENTS AND METHODS: Patients with and without uveitis eligible for cataract surgery were randomised to receive a hydrophobic or a hydrophilic square-edged intraocular lens (IOL). Patients undergoing bilateral surgery received a hydrophobic IOL in one eye and a hydrophilic in the other. Visual acuity, flare, and central foveal thickness were used as outcome measures.
RESULTS: In total, 34 (61%) patients (52 eyes) with uveitis and 22 (39%) non-uveitic patients (38 eyes) were included in the study. Comparable corrected distance visual acuity (CDVA) was seen, regardless of IOL material. Flare, six months postoperatively, for those undergoing bilateral surgery, showed no significant difference between eyes receiving a hydrophilic IOL or a hydrophobic IOL; mean difference was -3.2 (SD ± 20.7) ph/ms between eyes with uveitis (p = 0.53) and -0.6 SD ± 7.5 ph/ms between eyes without uveitis (p = 0.77). No significant difference in cystoid macular edema (CME) was seen for uveitic patients receiving a hydrophobic IOL (n = 2; 8.0%) and those receiving a hydrophilic IOL (n = 6; 22.2%; p = 0.25).
CONCLUSION: No significant differences in postoperative inflammatory reaction or rate of CME were seen regardless of using a hydrophobic or a hydrophilic IOL. In general, an improvement in CDVA was seen after cataract surgery with both types of IOLs. Thus, the present study did not support either of the IOL materials as advantageous in patients with uveitis.
Place, publisher, year, edition, pages
Dove Medical Press, 2025. Vol. 19, p. 373-383
Keywords [en]
Biocompatibility, cataract, complications, implant, inflammation
National Category
Ophthalmology
Identifiers
URN: urn:nbn:se:oru:diva-119205DOI: 10.2147/OPTH.S493398ISI: 001423183000001PubMedID: 39926313Scopus ID: 2-s2.0-85218129855OAI: oai:DiVA.org:oru-119205DiVA, id: diva2:1936500
Funder
Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
Note
Funding Agencies:
The study was financed by grants from the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALF-GBG-441721 and ALF-GBG-725041), Konung Gustav and Drottning Victorias Frimurarstiftelse (Swedish Order of Freemasons), and De Blindas Vänner.
2025-02-112025-02-112025-03-04Bibliographically approved